These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8231833)

  • 1. Glucose modulation of islet monoamine oxidase activity in lean and obese hyperglycemic mice.
    Panagiotidis G; Lindström P; Stenström A; Lundquist I
    Metabolism; 1993 Nov; 42(11):1398-404. PubMed ID: 8231833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of beta 2-adrenoceptor stimulation and glucose on islet monoamine oxidase activity and insulin secretory response in the mouse.
    Panagiotidis G; Stenström A; Lundquist I
    Pancreas; 1993 May; 8(3):368-74. PubMed ID: 8387193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysosomal enzyme activities in pancreatic islets from normal and obese hyperglycemic mice.
    Lundquist I
    Metabolism; 1985 Jan; 34(1):1-9. PubMed ID: 3917527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of adrenergic and cholinergic stimulation on islet monoamine oxidase activity and insulin secretion in the mouse.
    Panagiotidis G; Stenström A; Lundquist I
    Eur J Pharmacol; 1993 Mar; 233(2-3):285-90. PubMed ID: 8096820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of L-dopa administration on islet monoamine oxidase activity and glucose-induced insulin release in the mouse.
    Lundquist I; Panagiotidis G; Stenström A
    Pancreas; 1991 Sep; 6(5):522-7. PubMed ID: 1946308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoamine oxidase (MAO) in pancreatic islets of the mouse: some characteristics and the effect of chemical sympathectomy.
    Stenström A; Panagiotidis G; Lundquist I
    Diabetes Res; 1989 Jun; 11(2):81-4. PubMed ID: 2515934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of pancreatic islet monoamine oxidase by adrenergic antagonists and ethanol.
    Feldman JM
    Endocr Res Commun; 1975; 2(8):503-20. PubMed ID: 4295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Islet lysosomal enzyme activities and plasma insulin levels in obese hyperglycemic mice following injection of the lysosomotropic drug suramin.
    Lundquist I
    Diabetes Res; 1985 Jul; 2(4):207-11. PubMed ID: 3936659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoamine oxidase inhibitors: nature of their interaction with rabbit pancreatic islets to alter insluin secretion.
    Feldman JM; Chapman B
    Diabetologia; 1975 Dec; 11(6):487-94. PubMed ID: 1107123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormally decreased NO and augmented CO production in islets of the leptin-deficient ob/ob mouse might contribute to explain hyperinsulinemia and islet survival in leptin-resistant type 2 obese diabetes.
    Jimenez-Feltstrom J; Salehi A; Meidute Abaraviciene S; Henningsson R; Lundquist I
    Regul Pept; 2011 Oct; 170(1-3):43-51. PubMed ID: 21620903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of pancreatic islet monoamine oxidase.
    Feldman JM; Chapman B
    Metabolism; 1975 May; 24(5):581-8. PubMed ID: 1092954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine agonist treatment ameliorates hyperglycemia, hyperlipidemia, and the elevated basal insulin release from islets of ob/ob mice.
    Liang Y; Lubkin M; Sheng H; Scislowski PW; Cincotta AH
    Biochim Biophys Acta; 1998 Oct; 1405(1-3):1-13. PubMed ID: 9784590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic islets of obese hyperglycemic mice (ob/ob).
    Tomita T; Doull V; Pollock HG; Krizsan D
    Pancreas; 1992; 7(3):367-75. PubMed ID: 1594559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of insulin secretory function in young obese hyperglycemic mice (Umeå ob/ob).
    Edvell A; Lindström P
    Metabolism; 1995 Jul; 44(7):906-13. PubMed ID: 7616850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin production by pancreatic islets of obese-hyperglycemic mice cultured for one week in different glucose concentrations.
    Andersson A; Asplund K; Larkins R
    Acta Physiol Scand; 1978 Dec; 104(4):377-85. PubMed ID: 364930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional abnormalities of islets of Langerhans of obese hyperglycemic mouse.
    Lavine RL; Voyles N; Perrino PV; Recant L
    Am J Physiol; 1977 Aug; 233(2):E86-90. PubMed ID: 329686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity of endogenous substrates for types A and B monoamine oxidase in rat striatum.
    Schoepp DD; Azzaro AJ
    J Neurochem; 1981 Jun; 36(6):2025-31. PubMed ID: 6787175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential changes in islet lysosomal enzyme activities in aging obese hyperglycemic mice.
    Lundquist I
    Diabetes Res; 1986 Jan; 3(1):25-30. PubMed ID: 3082567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenethylamine is a substrate of monoamine oxidase B in the paraventricular thalamic nucleus.
    Obata Y; Kubota-Sakashita M; Kasahara T; Mizuno M; Nemoto T; Kato T
    Sci Rep; 2022 Jan; 12(1):17. PubMed ID: 34996979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose and insulin regulate glycosylphosphatidylinositol-specific phospholipase D expression in islet beta cells.
    Bowen RF; Raikwar NS; Olson LK; Deeg MA
    Metabolism; 2001 Dec; 50(12):1489-92. PubMed ID: 11735099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.